The biotech sector has been one of the best performers, which is in large part due to how biotech stocks are maturing. One prime example is Medivation Inc (NASDAQ:MDVN). A decade or two ago, most biotechs were still on the fringes of …
The stock in the Biotechnology industry, Medivation, Inc. (MDVN) could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings …
David Miller of Biotech Stock Research, among others, recently commented that trading patterns in the two stocks seem to confirm traders are going short DNDN and long MDVN in paired trades of significant sizes. Among other things, this …
Just as a reminder, MDVN is an Aggressive stock. So, you should stick with my 60%, 30%, 10% rule with MDVN stock. Keeping that in mind, Medivation is a “strong buy.”
Biogen closed Wednesday up over 1% at $305.69. Medivation Inc. (NASDAQ: MDVN) is a stock the Stifel analyst are very bullish on, and they are way above street estimates for earnings. They attribute the higher number to higher forecast …
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only ... At Medivation ( MDVN), a filing with the SEC revealed that on Friday, …
But the FDA was presumably able to review XTANDI's phase III data quite rapidly. XTANDI was approved on August 31st. The prolonged rally in MDVN stock can be traced back to a press release on November 3rd, 2011 that had statements …
MDVN’s niche is research into other diseases for which few treatment options exist, but none of this new research is close enough to warrant owning the stock at $129 a share. Well, yipsee doodle dandy, I like your selection of Universal …
Medivation, Inc. (MDVN) has been on the move lately as the stock has risen by 10.9% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on …
Deutsche Bank has a rating of Hold on the stock and a $26 price target. The consensus target is higher at $27.09. Shares closed trading at $25.13. Medivation Inc. (NASDAQ: MDVN) is a stock many Wall Street analysts are very bullish on. …